Why is SMS Pharmaceuticals Ltd falling/rising?

Recent Price Movement and Market Performance

The stock has underperformed significantly over the past week, registering a decline of 9.46%, compared to the Sensex’s modest fall of 0.75% during the same period. Today’s trading session opened with a gap down of 2.43%, signalling immediate bearish sentiment among investors. The share price touched an intraday low of ₹311.85, marking a 6.38% drop from the previous close. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting stronger selling interest at lower price levels.

Despite this recent weakness, SMS Pharmaceuticals continues to maintain its position above its 50-day, 100-day, and 200-day moving averages, although it remains below the shorter-term 5-day and 20-day averages. This technical setup points to a short-term correction within a longer-term uptrend.

Investor Participation and Liquidity Trends

Investor participation has waned in recent sessions, with delivery volumes on 16 Jan falling by over 40% compared to the five-day average. This decline in active buying interest may have contributed to the stock’s inability to sustain higher price levels. Nevertheless, liquidity remains adequate, with the stock’s traded value supporting transactions up to ₹0.21 crore without significant market impact.

Fundamental Strengths Supporting the Stock

While the short-term price action appears negative, SMS Pharmaceuticals boasts strong fundamental credentials that justify a hold stance for investors. The company reported net sales of ₹438.48 crore in the latest six-month period, reflecting a healthy growth rate of 21.40%. Its return on capital employed (ROCE) stands at a robust 12.36%, the highest in its recent half-yearly results, indicating efficient utilisation of capital.

Additionally, the company maintains a conservative capital structure, with a debt-to-equity ratio of just 0.45 times, the lowest recorded in the half-yearly data. This prudent financial management reduces risk and provides flexibility for future growth initiatives.

Promoters continue to hold a majority stake, signalling confidence in the company’s prospects. Over the past year, SMS Pharmaceuticals has delivered impressive returns of 41.08%, significantly outperforming the Sensex’s 8.65% gain. Its three-year returns are even more striking at nearly 294%, dwarfing the benchmark’s 36.79% rise, underscoring the stock’s consistent long-term performance.

Balancing Short-Term Volatility with Long-Term Potential

The recent decline in SMS Pharmaceuticals’ share price appears to be driven primarily by short-term profit-taking and reduced investor participation rather than any deterioration in the company’s fundamentals. The stock’s outperformance over multiple time horizons, including a five-year return of 167.08% compared to the Sensex’s 68.52%, highlights its resilience and growth potential.

Investors should note that the current price correction may offer an opportunity to accumulate shares at more attractive valuations, especially given the company’s strong sales growth, efficient capital use, and low leverage. However, the short-term technical indicators suggest caution until the stock stabilises above its recent moving averages.

In summary, SMS Pharmaceuticals Ltd is experiencing a temporary pullback amid broader market fluctuations and reduced buying interest. Its solid financial performance and consistent long-term returns provide a foundation for recovery, making it a stock to watch closely in the coming weeks.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →